TTM
$1.61B
YoY change
+19.1%
5Y CAGR
-4.0%
Peak year (2021)
$2.38B
Cumulative operating income
$31.02B
Operating Income history chart for Quest Diagnostics (DGX) from 1996 to 2025
Latest: $1.60B
Operating Income growth chart for Quest Diagnostics (DGX) from 1996 to 2025
Latest: +19.1%
Operating Income history table for Quest Diagnostics (DGX) from 1996 to 2025
| 2025 | $1.60B | +19.1% | +$257.00M | ||
| 2024 | $1.35B | +6.7% | +$84.00M | ||
| 2023 | $1.26B | -11.6% | −$166.00M | ||
| 2022 | $1.43B | -40.0% | −$953.00M | ||
| 2021 | $2.38B | +20.8% | +$410.00M | ||
| 2020 | $1.97B | +60.1% | +$740.00M | ||
| 2019 | $1.23B | +11.8% | +$130.00M | ||
| 2018 | $1.10B | -5.5% | −$64.00M | ||
| 2017 | $1.17B | -8.8% | −$112.00M | ||
| 2016 | $1.28B | -8.7% | −$122.00M | ||
| 2015 | $1.40B | +42.3% | +$416.00M | ||
| 2014 | $983.00M | -33.4% | −$492.00M | ||
| 2013 | $1.48B | +22.8% | +$274.20M | ||
| 2012 | $1.20B | +20.7% | +$205.80M | ||
| 2011 | $995.00M | -23.2% | −$300.50M | ||
| 2010 | $1.30B | -4.7% | −$63.60M | ||
| 2009 | $1.36B | +11.2% | +$136.70M | ||
| 2008 | $1.22B | +12.0% | +$131.06M | ||
| 2007 | $1.09B | -3.3% | −$36.67M | ||
| 2006 | $1.13B | +16.5% | +$159.90M | ||
| 2005 | $968.11M | +7.4% | +$66.67M | ||
| 2004 | $901.44M | +13.3% | +$106.01M | ||
| 2003 | $795.43M | +34.3% | +$202.99M | ||
| 2002 | $592.45M | +44.0% | +$181.06M | ||
| 2001 | $411.39M | +29.4% | +$93.57M | ||
| 2000 | $317.82M | +109.1% | +$165.82M | ||
| 1999 | $152.00M | +61.2% | +$57.70M | ||
| 1998 | $94.30M | +26.2% | +$19.60M | ||
| 1997 | $74.70M | -112.4% | +$675.98M | ||
| 1996 | −$601.28M | — | — |
- 2025$1.60B+19.1%
- 2024$1.35B+6.7%
- 2023$1.26B-11.6%
- 2022$1.43B-40.0%
- 2021$2.38B+20.8%
- 2020$1.97B+60.1%
- 2019$1.23B+11.8%
- 2018$1.10B-5.5%
- 2017$1.17B-8.8%
- 2016$1.28B-8.7%
- 2015$1.40B+42.3%
- 2014$983.00M-33.4%
- 2013$1.48B+22.8%
- 2012$1.20B+20.7%
- 2011$995.00M-23.2%
- 2010$1.30B-4.7%
- 2009$1.36B+11.2%
- 2008$1.22B+12.0%
- 2007$1.09B-3.3%
- 2006$1.13B+16.5%
- 2005$968.11M+7.4%
- 2004$901.44M+13.3%
- 2003$795.43M+34.3%
- 2002$592.45M+44.0%
- 2001$411.39M+29.4%
- 2000$317.82M+109.1%
- 1999$152.00M+61.2%
- 1998$94.30M+26.2%
- 1997$74.70M-112.4%
- 1996−$601.28M—
Operating Income values are taken from Quest Diagnostics's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Income at Quest Diagnostics (DGX)
According to Quest Diagnostics's latest reported financial statements, the company's current operating income (TTM) is $1.61B. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, Quest Diagnostics (DGX) operating income totalled $1.60B – grew 19.1% year-over-year.
Through 2020–2025 (5 years), Quest Diagnostics operating income delivered a -4.0% annualised rate; sustaining 2 straight years of year-over-year growth.
Between 2021 and 2025, Quest Diagnostics operating income plunged 32.7%, falling from $2.38B to $1.60B.
The highest annual operating income of $2.38B was reported in 2021. The lowest in the available history was −$601.28M in 1996.
Quest Diagnostics Operating Income by Year
Quest Diagnostics Operating Income 2025: $1.60B
Quest Diagnostics operating income in 2025 was $1.60B, grew 19.1% from 2024.
Quest Diagnostics Operating Income 2024: $1.35B
2024's operating income for Quest Diagnostics came in at $1.35B, grew 6.7% from 2023.
Quest Diagnostics Operating Income 2023: $1.26B
Quest Diagnostics posted operating income of $1.26B in 2023, declined 11.6% below 2022.
Quest Diagnostics Operating Income 2022: $1.43B
In 2022, Quest Diagnostics reported operating income of $1.43B, plunged 40.0% below 2021.
Quest Diagnostics Operating Income 2021: $2.38B
Quest Diagnostics operating income in 2021 was $2.38B.
See more financial history for Quest Diagnostics (DGX).
Sector peers by Operating Income
Healthcare peers of Quest Diagnostics (DGX), ranked by their latest operating income
| $29.70B | |
| $25.60B | |
| $23.49B | |
| $20.09B | |
| $19.90B | |
| $18.96B | |
| $13.74B | |
| $10.68B |
- $29.70B
- $25.60B
- $23.49B
- $20.09B
- $19.90B
- $18.96B
- $13.74B
- $10.68B
Frequently asked questions
Quest Diagnostics (DGX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation